The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis

Published:2018-12-20 Issue:5 Volume:29 Page:775-781
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Suto Takahito¹,Yonemoto Yukio¹,Okamura Koichi¹,Sakane Hideo¹,Takeuchi Kimihiko²,Tamura Yasuyuki³,Kaneko Tetsuya⁴,Ayabe Keio⁵,Chikuda Hirotaka¹

Affiliation:

1. Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan;

2. Department of Rheumatology, Isesaki Fukushima Hospital, Gunma, Japan;

3. Department of Orthopaedic Surgery, Inoue Hospital, Gunma, Japan;

4. Department of Orthopaedic Surgery, Japan Redcross Society Fukaya Redcross Hospital, Saitama, Japan;

5. Department of Orthopaedic Surgery, Keiyu Orthopaedic Hospital, Gunma, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2018.1510879

Reference31 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

2. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

3. Therapies for Active Rheumatoid Arthritis after Methotrexate Failure

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

5. T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis;Chinese Medical Journal;2024-07-26

2. Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials;Frontiers in Pharmacology;2023-12-07

3. AB0971 EFFECTIVENESS OF IGURATIMOD IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS-REAL WORLD DATA FROM CHINA;Scientific Abstracts;2023-05-30

4. A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials of Iguratimod Combined With Other Therapies for Sjogren’s Syndrome;Frontiers in Immunology;2022-07-28

5. The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial;Frontiers in Pharmacology;2022-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3